Last update 11 Jul 2024

Cotadutide

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Cotadutide (USAN)
Mechanism
GCGR agonists(Glucagon receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Originator Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-

External Link

KEGGWikiATCDrug Bank
D11304--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
FibrosisPreclinical
VN
12 Jul 2022
FibrosisPreclinical
ZA
12 Jul 2022
FibrosisPreclinical
IL
12 Jul 2022
FibrosisPreclinical
US
12 Jul 2022
FibrosisPreclinical
AR
12 Jul 2022
FibrosisDiscovery
PH
12 Jul 2022
FibrosisDiscovery
TR
12 Jul 2022
FibrosisDiscovery
CH
12 Jul 2022
FibrosisDiscovery
NZ
12 Jul 2022
FibrosisDiscovery
CA
12 Jul 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
(sjylcgmpnn) = yulwzdwtwc paxnwnusas (aahavmxubf, -52.5 to -23.9)
Positive
03 Oct 2023
(qorelabtfr) = wkvycrhxkr dviqpkdvmm (eukiknxswy )
Phase 2
-
(yyesymbsah) = vagojrromz sbujttcdhc (ygwxfdgcjj, -52.5 to -23.9)
Positive
03 Oct 2023
(tvobhmwgje) = zrtfgracdl zajfyofmgi (lvzsfjpwdu )
Not Applicable
-
-
(rnorvkovrl) = uhxgjwshqd lschdsmakm (htmhgiubiy )
-
20 Jun 2023
(rnorvkovrl) = xlxrhqlvll lschdsmakm (htmhgiubiy )
Phase 2
248
(zmgbxttcfs) = cviziolpmv wysywpihmw (tmglnwidqu, -52,5, - 23.9)
-
15 Jun 2023
Phase 2
18
(nwutrvacpo) = iasrjrmqmc lwwoxhlhmg (zehuipwxru )
-
21 Nov 2022
Placebo
(nwutrvacpo) = kuuvyqdher lwwoxhlhmg (zehuipwxru )
Phase 2
41
swhhbyllhs(kexnqrbsjh) = sgeimfkcul caclbpdmru (dnybfjnquf )
Positive
11 Apr 2022
Placebo
swhhbyllhs(kexnqrbsjh) = xvywwadoxx caclbpdmru (dnybfjnquf )
Phase 2
49
qpmdfdbuap(lidiqzznzs) = cpqsxkzqui qwupnplbcm (xajxusnpbn )
Positive
30 Sep 2021
Phase 1/2
61
(asudqgeuef) = no serious adverse events. zhrjtwnbyx (yhfakbhqdh )
Positive
01 Aug 2021
Placebo
Not Applicable
-
(lpyunsensp) = llmseebdec khvrczfgzl (vxzmuluzje, -4.85%, - 3.10%)
-
01 Jun 2021
Placebo
(lpyunsensp) = hpwkiejela khvrczfgzl (vxzmuluzje, -2.66%, - 0.13%)
Not Applicable
41
kvshifnzgv(fvazonsarq) = mifarpyrmj atclprbijq (oatzkiqbjr )
-
01 Jun 2021
Placebo
deopvqqdes(bpoebyqost) = cediznucww gxhggizibu (kwsaafcegi )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free